These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2556225)

  • 1. The effect of in vitro exposure to histamine on mononuclear leucocyte phosphodiesterase activity in atopic dermatitis.
    Holden CA; Yuen CT; Coulson IH
    Clin Exp Dermatol; 1989 May; 14(3):186-90. PubMed ID: 2556225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis.
    Sawai T; Ikai K; Uehara M
    Br J Dermatol; 1995 Jan; 132(1):22-4. PubMed ID: 7756148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered leukocyte protein kinase activity in atopic dermatitis.
    Trask DM; Chan SC; Sherman SE; Hanifin JM
    J Invest Dermatol; 1988 Apr; 90(4):526-31. PubMed ID: 3351335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased leukocyte sensitivity to phosphodiesterase inhibitors in atopic dermatitis: tachyphylaxis after theophylline therapy.
    Giustina TA; Chan SC; Thiel ML; Baker JW; Hanifin JM
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 1):252-7. PubMed ID: 6088608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered phosphorylation as a possible basis for cyclic nucleotide abnormalities in atopic dermatitis.
    Hanifin JM; Chan SC; Hirschman CA
    Acta Derm Venereol Suppl (Stockh); 1985; 120():47-9. PubMed ID: 3010615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy.
    Sawai T; Ikai K; Uehara M
    Br J Dermatol; 1998 May; 138(5):846-8. PubMed ID: 9666832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol metabolism in mononuclear leucocytes from patients with atopic dermatitis.
    Coulson IH; Hurt GR; Holden CA
    Br J Dermatol; 1991 Feb; 124(2):124-9. PubMed ID: 1848440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-interferon production in atopic dermatitis shows differential modification by phosphodiesterase and prostaglandin inhibition.
    Ostlere LS; Mallett RB; Kaminski A; Kaminski ER; Pereira RS; Holden CA
    Br J Dermatol; 1995 Jul; 133(1):1-5. PubMed ID: 7669618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis.
    Coulson IH; Duncan SN; Holden CA
    Br J Dermatol; 1989 May; 120(5):607-12. PubMed ID: 2547417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.
    Cooper KD; Kang K; Chan SC; Hanifin JM
    J Invest Dermatol; 1985 Jun; 84(6):477-82. PubMed ID: 3998494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of mononuclear leukocyte cyclic adenosine monophosphate-phosphodiesterase activity to treatment with topical fluorinated steroid ointment in atopic dermatitis.
    Holden CA; Yuen CT
    J Am Acad Dermatol; 1989 Jul; 21(1):69-74. PubMed ID: 2545750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis.
    Schopf RE; Weber H; Morsches B
    Arch Dermatol Res; 1993; 285(5):305-9. PubMed ID: 8379692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Butler JM; Ebertz M; Chan SC; Stevens SR; Sobieszczuk D; Hanifin JM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():55-60. PubMed ID: 2408432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase and immune dysfunction in atopic dermatitis.
    Hanifin JM
    J Dermatol Sci; 1990 Jan; 1(1):1-6. PubMed ID: 1964082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
    Butler JM; Chan SC; Stevens S; Hanifin JM
    J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacology of the atopic diseases.
    Hanifin JM; Butler JM; Chan SC
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):161s-164s. PubMed ID: 2409183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis.
    Chan SC; Kim JW; Henderson WR; Hanifin JM
    J Immunol; 1993 Sep; 151(6):3345-52. PubMed ID: 8397256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes.
    Chan SC; Grewe SR; Stevens SR; Hanifin JM
    J Cyclic Nucleotide Res; 1982; 8(4):211-24. PubMed ID: 6300207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenoceptor function in atopic dermatitis: in vitro and in vivo observations.
    Archer CB; Hanson JM; Morley J; MacDonald DM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():93-7. PubMed ID: 2860767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells.
    Yoshida N; Shimizu Y; Kitaichi K; Hiramatsu K; Takeuchi M; Ito Y; Kume H; Yamaki K; Suzuki R; Shibata E; Hasegawa T; Takagi K
    Clin Exp Immunol; 2001 Dec; 126(3):384-9. PubMed ID: 11737051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.